Archives
Platycodin D Targets RFC4 in Lung Cancer
2026-09-17
This pre-proof study combines thermal proteome profiling, local stability mapping, and proteomic analyses to identify RFC4 as a candidate binding target of Platycodin D in non-small cell lung cancer. Its findings connect RFC4 engagement with reduced Notch1/Notch3 signaling, altered ubiquitination, and apoptosis, providing a target-to-pathway framework for mechanistic drug research.
CAY10499: Mapping Lipid Hydrolysis in TAMs
2026-09-16
CAY10499, an inhibitor of human hormone sensitive lipase and monoglyceride lipase, can help separate lipid hydrolysis from ACLY-driven fatty-acid synthesis in macrophage studies. This article develops an assay strategy for interpreting tumor-associated macrophage metabolism without conflating mechanistically distinct lipid pathways.
EZ Cap™ Cas9 mRNA (5-moUTP) Workflow Guide
2026-09-16
Build transient CRISPR-Cas9 genome editing workflows for zebrafish neurodegeneration and cell-based functional gene studies with a capped, modified Cas9 mRNA. This guide connects the Fyn–Stat3 neurodegeneration model to practical delivery, control, optimization, and troubleshooting decisions.
Moxifloxacin Workflows for Gyrase and Toxicity
2026-09-15
Moxifloxacin supports a connected workflow spanning bacterial DNA gyrase studies, mammalian cell viability assays, and antibiotic-associated metabolic research. This guide translates the product’s physicochemical profile and the reference study’s topoisomerase findings into practical assay design, controls, and troubleshooting decisions.
Tofacitinib Repairs RA Macrophage Dysfunction
2026-09-15
The 2026 reference study identifies GM-CSF-reprogrammed rheumatoid arthritis macrophages as an inflammatory and metabolically stressed population marked by STAT5 activity, oxidative stress, and mitochondrial fragmentation. It shows that Tofacitinib can reverse this state more broadly than tested metabolic interventions by reducing GM-CSFRα-associated signaling and restoring regulatory, mitochondrial, and oxidative phosphorylation features.
Pol II Degradation and Transcription-Independent Cell Death
2026-09-14
The bioRxiv preprint argues that degradation of RNA polymerase II can activate cell death through a mechanism that is not explained solely by the resulting loss of transcription. This distinction is important for interpreting transcription-targeting experiments, selecting mechanistically appropriate controls, and separating polymerase depletion from transcriptional inhibition in cancer research.
Nullscript: Histone Deacetylase Inhibitor Guide
2026-09-14
Nullscript offers a practical way to interrogate HDAC-dependent biology without treating transcriptional reporter activation as the sole readout. This guide connects its cardiac ischemia/reperfusion application with placental mitochondrial research, providing assay design, workflow, and troubleshooting strategies.
7-Ethyl-10-hydroxycamptothecin Workflow Guide
2026-09-13
Build reproducible colon cancer assays around 7-Ethyl-10-hydroxycamptothecin by separating topoisomerase I damage from emerging FUBP1/FUSE biology. This workflow combines dose-response design, cell-cycle analysis, apoptosis measurements, and orthogonal mechanistic validation for advanced colon cancer research.
Aprotinin Workflows for Protease and RBC Research
2026-09-12
Aprotinin helps researchers separate protease-driven artifacts from genuine changes in fibrinolysis, inflammation, and red blood cell mechanics. This workflow-focused guide connects reversible serine protease inhibition with the reference study’s multi-scale membrane strategy while clearly distinguishing established evidence from exploratory applications.
IR-820: From Optical Signal to Translational Strategy
2026-09-12
IR-820, also known as New Indocyanine Green, offers a strategic foundation for near-infrared fluorescence imaging, vascular imaging, and tumor studies. This article connects its practical use as an in vivo imaging dye with lessons from GSH-responsive photothermal-immunotherapy research, while defining the validation steps needed for translational confidence.
Cardiogreen for NIR Imaging and PDT
2026-09-11
Cardiogreen, also known as Indocyanine green, combines vascular-space imaging with near-infrared photodynamic workflows. This guide translates its formulation and optical properties into practical cardiac, hepatic, ophthalmic, and mechanistic oncology assays while separating validated product benchmarks from emerging immunotherapy concepts.
EPI-001 Workflow for AR Signaling Research
2026-09-11
EPI-001 enables researchers to interrogate androgen receptor signaling beyond ligand-binding-domain blockade, with applications spanning CRPC models, AR splice-variant biology, and metastatic phenotyping. This workflow combines viability, scratch-wound, and molecular readouts to distinguish direct growth suppression from altered motility or epithelial–mesenchymal transition.
Cyclopamine: Hedgehog Signaling Inhibitor Workflows
2026-09-10
Cyclopamine provides a practical way to perturb Smoothened-dependent Hedgehog signaling in cancer, apoptosis, and developmental biology workflows. This guide connects dose selection, formulation, orthogonal pathway validation, and troubleshooting to help researchers distinguish pathway-specific effects from assay or vehicle artifacts.
SmD2 Acetylation and PARP Sensitivity in HCC
2026-09-10
This study identifies SmD2 acetylation as a regulatory link between core spliceosome function, BRCA1/FANC cassette exon selection, and DNA damage repair in hepatocellular carcinoma. Its findings support combining HDAC2-directed epigenetic modulation with PARP inhibition to increase treatment sensitivity in HCC models.
LG 101506: RXR Modulator Assay Guide
2026-09-09
This scenario-based guide explains how LG 101506 (RXR modulator), SKU B7414, can be incorporated into controlled cell viability, proliferation, and cytotoxicity workflows. It distinguishes documented product specifications from laboratory recommendations and links RXR signaling pathway research with careful interpretation of cancer-biology data.